866-997-4948(US-Canada Toll Free)

Global Microbiome Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published By :

Globalinforesearch

Published Date : Feb 2019

Category :

Pharmaceutical

No. of Pages : 138 Pages

The human microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us; in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.


Scope of the Report:
In the last several years, global market of Microbiome Therapeutics developed rapidly, with an average growth rate of 98%. In 2017, Global Market Size of Microbiome Therapeutics is nearly 14 M USD.
For developing product, there are 2 products in Phase 3, 7 products in Phase 2, 8 products in Phase 1 and 17 products in Preclinical. The total investment for Microbiome Therapeutics developing is around 293 M USD in 2017.
The Application of Microbiome Therapeutics includes CDI, IBD, Orphan Drug, Immuno-oncology and Others, and the proportion of R&D Investmen for CDI in 2016 is about 52%, and the proportion is in Increase trend from 2012 to 2016.
The worldwide market for Microbiome Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Microbiome Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Seres Therapeutics
Assembly Biosciences
Synthetic Biologics
Interxon
PureTech
Synlogic
Enterome BioScience
4D Pharma
Second Genome
AOBiome
C3 Jian
Rebiotix
MicroBiome Therapeutics LLC
Metabiomics
Ritter Pharmaceuticals
Symberix
OpenBiome
Azitra
Symbiotix Biotherapies
Osel
Metabogen

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Type I
Type II

Market Segment by Applications, can be divided into
Inflammatory Bowel Disease (IBD)
Orphan Drug
Immuno-oncology
Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Microbiome Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Microbiome Therapeutics, with price, sales, revenue and global market share of Microbiome Therapeutics in 2017 and 2018.
Chapter 3, the Microbiome Therapeutics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Microbiome Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Microbiome Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Microbiome Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents

1 Market Overview
1.1 Microbiome Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Type I
1.2.2 Type II
1.3 Market Analysis by Applications
1.3.1 Inflammatory Bowel Disease (IBD)
1.3.2 Orphan Drug
1.3.3 Immuno-oncology
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Seres Therapeutics
2.1.1 Business Overview
2.1.2 Microbiome Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Seres Therapeutics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Assembly Biosciences
2.2.1 Business Overview
2.2.2 Microbiome Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Assembly Biosciences Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Synthetic Biologics
2.3.1 Business Overview
2.3.2 Microbiome Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Synthetic Biologics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Interxon
2.4.1 Business Overview
2.4.2 Microbiome Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Interxon Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 PureTech
2.5.1 Business Overview
2.5.2 Microbiome Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 PureTech Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Synlogic
2.6.1 Business Overview
2.6.2 Microbiome Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Synlogic Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Enterome BioScience
2.7.1 Business Overview
2.7.2 Microbiome Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Enterome BioScience Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 4D Pharma
2.8.1 Business Overview
2.8.2 Microbiome Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 4D Pharma Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Second Genome
2.9.1 Business Overview
2.9.2 Microbiome Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Second Genome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 AOBiome
2.10.1 Business Overview
2.10.2 Microbiome Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 AOBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 C3 Jian
2.11.1 Business Overview
2.11.2 Microbiome Therapeutics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 C3 Jian Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Rebiotix
2.12.1 Business Overview
2.12.2 Microbiome Therapeutics Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Rebiotix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 MicroBiome Therapeutics LLC
2.13.1 Business Overview
2.13.2 Microbiome Therapeutics Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 Metabiomics
2.14.1 Business Overview
2.14.2 Microbiome Therapeutics Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Metabiomics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.15 Ritter Pharmaceuticals
2.15.1 Business Overview
2.15.2 Microbiome Therapeutics Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.16 Symberix
2.16.1 Business Overview
2.16.2 Microbiome Therapeutics Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Symberix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.17 OpenBiome
2.17.1 Business Overview
2.17.2 Microbiome Therapeutics Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 OpenBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.18 Azitra
2.18.1 Business Overview
2.18.2 Microbiome Therapeutics Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Azitra Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.19 Symbiotix Biotherapies
2.19.1 Business Overview
2.19.2 Microbiome Therapeutics Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Symbiotix Biotherapies Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.20 Osel
2.20.1 Business Overview
2.20.2 Microbiome Therapeutics Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Osel Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.21 Metabogen
2.21.1 Business Overview
2.2.2 Microbiome Therapeutics Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Metabogen Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Microbiome Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Microbiome Therapeutics Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Microbiome Therapeutics Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Microbiome Therapeutics Manufacturer Market Share in 2018
3.3.2 Top 6 Microbiome Therapeutics Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Microbiome Therapeutics Market Analysis by Regions
4.1 Global Microbiome Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Microbiome Therapeutics Sales and Market Share by Regions (2014-2019)
4.1.2 Global Microbiome Therapeutics Revenue and Market Share by Regions (2014-2019)
4.2 North America Microbiome Therapeutics Sales and Growth Rate (2014-2019)
4.3 Europe Microbiome Therapeutics Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Microbiome Therapeutics Sales and Growth Rate (2014-2019)
4.5 South America Microbiome Therapeutics Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Microbiome Therapeutics Sales and Growth Rate (2014-2019)
5 North America Microbiome Therapeutics by Country
5.1 North America Microbiome Therapeutics Sales, Revenue and Market Share by Country
5.1.1 North America Microbiome Therapeutics Sales and Market Share by Country (2014-2019)
5.1.2 North America Microbiome Therapeutics Revenue and Market Share by Country (2014-2019)
5.2 United States Microbiome Therapeutics Sales and Growth Rate (2014-2019)
5.3 Canada Microbiome Therapeutics Sales and Growth Rate (2014-2019)
5.4 Mexico Microbiome Therapeutics Sales and Growth Rate (2014-2019)
6 Europe Microbiome Therapeutics by Country
6.1 Europe Microbiome Therapeutics Sales, Revenue and Market Share by Country
6.1.1 Europe Microbiome Therapeutics Sales and Market Share by Country (2014-2019)
6.1.2 Europe Microbiome Therapeutics Revenue and Market Share by Country (2014-2019)
6.2 Germany Microbiome Therapeutics Sales and Growth Rate (2014-2019)
6.3 UK Microbiome Therapeutics Sales and Growth Rate (2014-2019)
6.4 France Microbiome Therapeutics Sales and Growth Rate (2014-2019)
6.5 Russia Microbiome Therapeutics Sales and Growth Rate (2014-2019)
6.6 Italy Microbiome Therapeutics Sales and Growth Rate (2014-2019)
7 Asia-Pacific Microbiome Therapeutics by Country
7.1 Asia-Pacific Microbiome Therapeutics Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Microbiome Therapeutics Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Microbiome Therapeutics Revenue and Market Share by Country (2014-2019)
7.2 China Microbiome Therapeutics Sales and Growth Rate (2014-2019)
7.3 Japan Microbiome Therapeutics Sales and Growth Rate (2014-2019)
7.4 Korea Microbiome Therapeutics Sales and Growth Rate (2014-2019)
7.5 India Microbiome Therapeutics Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Microbiome Therapeutics Sales and Growth Rate (2014-2019)
8 South America Microbiome Therapeutics by Country
8.1 South America Microbiome Therapeutics Sales, Revenue and Market Share by Country
8.1.1 South America Microbiome Therapeutics Sales and Market Share by Country (2014-2019)
8.1.2 South America Microbiome Therapeutics Revenue and Market Share by Country (2014-2019)
8.2 Brazil Microbiome Therapeutics Sales and Growth Rate (2014-2019)
8.3 Argentina Microbiome Therapeutics Sales and Growth Rate (2014-2019)
8.4 Colombia Microbiome Therapeutics Sales and Growth Rate (2014-2019)
9 Middle East and Africa Microbiome Therapeutics by Countries
9.1 Middle East and Africa Microbiome Therapeutics Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Microbiome Therapeutics Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Microbiome Therapeutics Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Microbiome Therapeutics Sales and Growth Rate (2014-2019)
9.3 Turkey Microbiome Therapeutics Sales and Growth Rate (2014-2019)
9.4 Egypt Microbiome Therapeutics Sales and Growth Rate (2014-2019)
9.5 Nigeria Microbiome Therapeutics Sales and Growth Rate (2014-2019)
9.6 South Africa Microbiome Therapeutics Sales and Growth Rate (2014-2019)
10 Global Microbiome Therapeutics Market Segment by Type
10.1 Global Microbiome Therapeutics Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Microbiome Therapeutics Sales and Market Share by Type (2014-2019)
10.1.2 Global Microbiome Therapeutics Revenue and Market Share by Type (2014-2019)
10.2 Type I Sales Growth and Price
10.2.1 Global Type I Sales Growth (2014-2019)
10.2.2 Global Type I Price (2014-2019)
10.3 Type II Sales Growth and Price
10.3.1 Global Type II Sales Growth (2014-2019)
10.3.2 Global Type II Price (2014-2019)
11 Global Microbiome Therapeutics Market Segment by Application
11.1 Global Microbiome Therapeutics Sales Market Share by Application (2014-2019)
11.2 Inflammatory Bowel Disease (IBD) Sales Growth (2014-2019)
11.3 Orphan Drug Sales Growth (2014-2019)
11.4 Immuno-oncology Sales Growth (2014-2019)
11.5 Others Sales Growth (2014-2019)
12 Microbiome Therapeutics Market Forecast (2019-2024)
12.1 Global Microbiome Therapeutics Sales, Revenue and Growth Rate (2019-2024)
12.2 Microbiome Therapeutics Market Forecast by Regions (2019-2024)
12.2.1 North America Microbiome Therapeutics Market Forecast (2019-2024)
12.2.2 Europe Microbiome Therapeutics Market Forecast (2019-2024)
12.2.3 Asia-Pacific Microbiome Therapeutics Market Forecast (2019-2024)
12.2.4 South America Microbiome Therapeutics Market Forecast (2019-2024)
12.2.5 Middle East and Africa Microbiome Therapeutics Market Forecast (2019-2024)
12.3 Microbiome Therapeutics Market Forecast by Type (2019-2024)
12.3.1 Global Microbiome Therapeutics Sales Forecast by Type (2019-2024)
12.3.2 Global Microbiome Therapeutics Market Share Forecast by Type (2019-2024)
12.4 Microbiome Therapeutics Market Forecast by Application (2019-2024)
12.4.1 Global Microbiome Therapeutics Sales Forecast by Application (2019-2024)
12.4.2 Global Microbiome Therapeutics Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Table

List of Tables and Figures

Figure Microbiome Therapeutics Picture
Table Product Specifications of Microbiome Therapeutics
Figure Global Sales Market Share of Microbiome Therapeutics by Types in 2018
Table Microbiome Therapeutics Types for Major Manufacturers
Figure Type I Picture
Figure Type II Picture
Figure Microbiome Therapeutics Sales Market Share by Applications in 2018
Figure Inflammatory Bowel Disease (IBD) Picture
Figure Orphan Drug Picture
Figure Immuno-oncology Picture
Figure Others Picture
Figure United States Microbiome Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Microbiome Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Microbiome Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Microbiome Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure France Microbiome Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure UK Microbiome Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Microbiome Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Microbiome Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure China Microbiome Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Microbiome Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Microbiome Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure India Microbiome Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Microbiome Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Microbiome Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Microbiome Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Microbiome Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Microbiome Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Microbiome Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Table Seres Therapeutics Basic Information, Manufacturing Base and Competitors
Table Seres Therapeutics Microbiome Therapeutics Type and Applications
Table Seres Therapeutics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Assembly Biosciences Basic Information, Manufacturing Base and Competitors
Table Assembly Biosciences Microbiome Therapeutics Type and Applications
Table Assembly Biosciences Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Synthetic Biologics Basic Information, Manufacturing Base and Competitors
Table Synthetic Biologics Microbiome Therapeutics Type and Applications
Table Synthetic Biologics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Interxon Basic Information, Manufacturing Base and Competitors
Table Interxon Microbiome Therapeutics Type and Applications
Table Interxon Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table PureTech Basic Information, Manufacturing Base and Competitors
Table PureTech Microbiome Therapeutics Type and Applications
Table PureTech Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Synlogic Basic Information, Manufacturing Base and Competitors
Table Synlogic Microbiome Therapeutics Type and Applications
Table Synlogic Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Enterome BioScience Basic Information, Manufacturing Base and Competitors
Table Enterome BioScience Microbiome Therapeutics Type and Applications
Table Enterome BioScience Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table 4D Pharma Basic Information, Manufacturing Base and Competitors
Table 4D Pharma Microbiome Therapeutics Type and Applications
Table 4D Pharma Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Second Genome Basic Information, Manufacturing Base and Competitors
Table Second Genome Microbiome Therapeutics Type and Applications
Table Second Genome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table AOBiome Basic Information, Manufacturing Base and Competitors
Table AOBiome Microbiome Therapeutics Type and Applications
Table AOBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table C3 Jian Basic Information, Manufacturing Base and Competitors
Table C3 Jian Microbiome Therapeutics Type and Applications
Table C3 Jian Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Rebiotix Basic Information, Manufacturing Base and Competitors
Table Rebiotix Microbiome Therapeutics Type and Applications
Table Rebiotix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table MicroBiome Therapeutics LLC Basic Information, Manufacturing Base and Competitors
Table MicroBiome Therapeutics LLC Microbiome Therapeutics Type and Applications
Table MicroBiome Therapeutics LLC Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Metabiomics Basic Information, Manufacturing Base and Competitors
Table Metabiomics Microbiome Therapeutics Type and Applications
Table Metabiomics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Ritter Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ritter Pharmaceuticals Microbiome Therapeutics Type and Applications
Table Ritter Pharmaceuticals Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Symberix Basic Information, Manufacturing Base and Competitors
Table Symberix Microbiome Therapeutics Type and Applications
Table Symberix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table OpenBiome Basic Information, Manufacturing Base and Competitors
Table OpenBiome Microbiome Therapeutics Type and Applications
Table OpenBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Azitra Basic Information, Manufacturing Base and Competitors
Table Azitra Microbiome Therapeutics Type and Applications
Table Azitra Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Symbiotix Biotherapies Basic Information, Manufacturing Base and Competitors
Table Symbiotix Biotherapies Microbiome Therapeutics Type and Applications
Table Symbiotix Biotherapies Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Osel Basic Information, Manufacturing Base and Competitors
Table Osel Microbiome Therapeutics Type and Applications
Table Osel Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Metabogen Basic Information, Manufacturing Base and Competitors
Table Metabogen Microbiome Therapeutics Type and Applications
Table Metabogen Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Microbiome Therapeutics Sales by Manufacturer (2017-2018)
Figure Global Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Figure Global Microbiome Therapeutics Sales Market Share by Manufacturer in 2018
Table Global Microbiome Therapeutics Revenue by Manufacturer (2017-2018)
Figure Global Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Figure Global Microbiome Therapeutics Revenue Market Share by Manufacturer in 2018
Figure Top 3 Microbiome Therapeutics Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Microbiome Therapeutics Manufacturer (Revenue) Market Share in 2018
Figure Global Microbiome Therapeutics Sales and Growth Rate (2014-2019)
Figure Global Microbiome Therapeutics Revenue and Growth Rate (2014-2019)
Table Global Microbiome Therapeutics Sales by Regions (2014-2019)
Table Global Microbiome Therapeutics Sales Market Share by Regions (2014-2019)
Table Global Microbiome Therapeutics Revenue by Regions (2014-2019)
Figure Global Microbiome Therapeutics Revenue Market Share by Regions in 2014
Figure Global Microbiome Therapeutics Revenue Market Share by Regions in 2018
Figure North America Microbiome Therapeutics Sales and Growth Rate (2014-2019)
Figure Europe Microbiome Therapeutics Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Microbiome Therapeutics Sales and Growth Rate (2014-2019)
Figure South America Microbiome Therapeutics Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Microbiome Therapeutics Sales and Growth Rate (2014-2019)
Figure North America Microbiome Therapeutics Revenue and Growth Rate (2014-2019)
Table North America Microbiome Therapeutics Sales by Countries (2014-2019)
Table North America Microbiome Therapeutics Sales Market Share by Countries (2014-2019)
Figure North America Microbiome Therapeutics Sales Market Share by Countries in 2014
Figure North America Microbiome Therapeutics Sales Market Share by Countries in 2018
Table North America Microbiome Therapeutics Revenue by Countries (2014-2019)
Table North America Microbiome Therapeutics Revenue Market Share by Countries (2014-2019)
Figure North America Microbiome Therapeutics Revenue Market Share by Countries in 2014
Figure North America Microbiome Therapeutics Revenue Market Share by Countries in 2018
Figure United States Microbiome Therapeutics Sales and Growth Rate (2014-2019)
Figure Canada Microbiome Therapeutics Sales and Growth Rate (2014-2019)
Figure Mexico Microbiome Therapeutics Sales and Growth Rate (2014-2019)
Figure Europe Microbiome Therapeutics Revenue and Growth Rate (2014-2019)
Table Europe Microbiome Therapeutics Sales by Countries (2014-2019)
Table Europe Microbiome Therapeutics Sales Market Share by Countries (2014-2019)
Table Europe Microbiome Therapeutics Revenue by Countries (2014-2019)
Figure Europe Microbiome Therapeutics Revenue Market Share by Countries in 2017
Figure Europe Microbiome Therapeutics Revenue Market Share by Countries in 2018
Figure Germany Microbiome Therapeutics Sales and Growth Rate (2014-2019)
Figure UK Microbiome Therapeutics Sales and Growth Rate (2014-2019)
Figure France Microbiome Therapeutics Sales and Growth Rate (2014-2019)
Figure Russia Microbiome Therapeutics Sales and Growth Rate (2014-2019)
Figure Italy Microbiome Therapeutics Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Microbiome Therapeutics Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Microbiome Therapeutics Sales by Countries (2014-2019)
Table Asia-Pacific Microbiome Therapeutics Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Microbiome Therapeutics Sales Market Share by Countries 2018
Table Asia-Pacific Microbiome Therapeutics Revenue by Countries (2014-2019)
Figure Asia-Pacific Microbiome Therapeutics Revenue Market Share by Countries 2018
Figure China Microbiome Therapeutics Sales and Growth Rate (2014-2019)
Figure Japan Microbiome Therapeutics Sales and Growth Rate (2014-2019)
Figure Korea Microbiome Therapeutics Sales and Growth Rate (2014-2019)
Figure India Microbiome Therapeutics Sales and Growth Rate (2014-2019)
Figure Southeast Asia Microbiome Therapeutics Sales and Growth Rate (2014-2019)
Figure South America Microbiome Therapeutics Revenue and Growth Rate (2014-2019)
Table South America Microbiome Therapeutics Sales by Countries (2014-2019)
Table South America Microbiome Therapeutics Sales Market Share by Countries (2014-2019)
Figure South America Microbiome Therapeutics Sales Market Share by Countries in 2018
Table South America Microbiome Therapeutics Revenue by Countries (2014-2019)
Table South America Microbiome Therapeutics Revenue Market Share by Countries (2014-2019)
Figure South America Microbiome Therapeutics Revenue Market Share by Countries in 2018
Figure Brazil Microbiome Therapeutics Sales and Growth Rate (2014-2019)
Figure Argentina Microbiome Therapeutics Sales and Growth Rate (2014-2019)
Figure Colombia Microbiome Therapeutics Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Microbiome Therapeutics Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Microbiome Therapeutics Sales by Countries (2014-2019)
Table Middle East and Africa Microbiome Therapeutics Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Microbiome Therapeutics Sales Market Share by Countries in 2018
Table Middle East and Africa Microbiome Therapeutics Revenue by Countries (2014-2019)
Table Middle East and Africa Microbiome Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Microbiome Therapeutics Revenue Market Share by Countries in 2014
Figure Middle East and Africa Microbiome Therapeutics Revenue Market Share by Countries in 2018
Figure Saudi Arabia Microbiome Therapeutics Sales and Growth Rate (2014-2019)
Figure UAE Microbiome Therapeutics Sales and Growth Rate (2014-2019)
Figure Egypt Microbiome Therapeutics Sales and Growth Rate (2014-2019)
Figure Nigeria Microbiome Therapeutics Sales and Growth Rate (2014-2019)
Figure South Africa Microbiome Therapeutics Sales and Growth Rate (2014-2019)
Table Global Microbiome Therapeutics Sales by Type (2014-2019)
Table Global Microbiome Therapeutics Sales Share by Type (2014-2019)
Table Global Microbiome Therapeutics Revenue by Type (2014-2019)
Table Global Microbiome Therapeutics Revenue Share by Type (2014-2019)
Figure Global Type I Sales Growth (2014-2019)
Figure Global Type I Price (2014-2019)
Figure Global Type II Sales Growth (2014-2019)
Figure Global Type II Price (2014-2019)
Table Global Microbiome Therapeutics Sales by Application (2014-2019)
Table Global Microbiome Therapeutics Sales Share by Application (2014-2019)
Figure Global Orphan Drug Sales Growth (2014-2019)
Figure Global Immuno-oncology Sales Growth (2014-2019)
Figure Global Others Sales Growth (2014-2019)
Figure Global Microbiome Therapeutics Sales, Revenue and Growth Rate (2019-2024)
Table Global Microbiome Therapeutics Sales Forecast by Regions (2019-2024)
Table Global Microbiome Therapeutics Market Share Forecast by Regions (2019-2024)
Figure North America Sales Microbiome Therapeutics Market Forecast (2019-2024)
Figure Europe Sales Microbiome Therapeutics Market Forecast (2019-2024)
Figure Asia-Pacific Sales Microbiome Therapeutics Market Forecast (2019-2024)
Figure South America Sales Microbiome Therapeutics Market Forecast (2019-2024)
Figure Middle East and Africa Sales Microbiome Therapeutics Market Forecast (2019-2024)
Table Global Microbiome Therapeutics Sales Forecast by Type (2019-2024)
Table Global Microbiome Therapeutics Market Share Forecast by Type (2019-2024)
Table Global Microbiome Therapeutics Sales Forecast by Application (2019-2024)
Table Global Microbiome Therapeutics Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *